View in EDS HTML Full Text PDF Full Text

Glepaglutide, a novel glucagon-like peptide-2 agonist, has anti-inflammatory and mucosal regenerative effects in an experimental model of inflammatory bowel disease in rats.

Saved in:
Bibliographic Details
Title: Glepaglutide, a novel glucagon-like peptide-2 agonist, has anti-inflammatory and mucosal regenerative effects in an experimental model of inflammatory bowel disease in rats.
Authors: Skarbaliene J; Research and Development, Zealand Pharma A/S, Sydmarken 11, 2860, Søborg, Denmark.; Pharvaris GmbH, 6300, Grafenauweg 8, Zug, Switzerland., Mathiesen JM; Research and Development, Zealand Pharma A/S, Sydmarken 11, 2860, Søborg, Denmark. jmmathiesen@zealandpharma.com., Larsen BD; Research and Development, Zealand Pharma A/S, Sydmarken 11, 2860, Søborg, Denmark., Thorkildsen C; Research and Development, Zealand Pharma A/S, Sydmarken 11, 2860, Søborg, Denmark., Petersen YM; Research and Development, Zealand Pharma A/S, Sydmarken 11, 2860, Søborg, Denmark.; Hoffmann-La Roche, Grenzacherstrasse 124, 4070, Basel, Switzerland.
Source: BMC gastroenterology [BMC Gastroenterol] 2023 Mar 21; Vol. 23 (1), pp. 79. Date of Electronic Publication: 2023 Mar 21.
Publication Type: Journal Article
Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 100968547 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-230X (Electronic) Linking ISSN: 1471230X NLM ISO Abbreviation: BMC Gastroenterol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 36944922
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Glepaglutide, a novel glucagon-like peptide-2 agonist, has anti-inflammatory and mucosal regenerative effects in an experimental model of inflammatory bowel disease in rats.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Skarbaliene+J%22">Skarbaliene J</searchLink>; Research and Development, Zealand Pharma A/S, Sydmarken 11, 2860, Søborg, Denmark.; Pharvaris GmbH, 6300, Grafenauweg 8, Zug, Switzerland.<br /><searchLink fieldCode="AU" term="%22Mathiesen+JM%22">Mathiesen JM</searchLink>; Research and Development, Zealand Pharma A/S, Sydmarken 11, 2860, Søborg, Denmark. jmmathiesen@zealandpharma.com.<br /><searchLink fieldCode="AU" term="%22Larsen+BD%22">Larsen BD</searchLink>; Research and Development, Zealand Pharma A/S, Sydmarken 11, 2860, Søborg, Denmark.<br /><searchLink fieldCode="AU" term="%22Thorkildsen+C%22">Thorkildsen C</searchLink>; Research and Development, Zealand Pharma A/S, Sydmarken 11, 2860, Søborg, Denmark.<br /><searchLink fieldCode="AU" term="%22Petersen+YM%22">Petersen YM</searchLink>; Research and Development, Zealand Pharma A/S, Sydmarken 11, 2860, Søborg, Denmark.; Hoffmann-La Roche, Grenzacherstrasse 124, 4070, Basel, Switzerland.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22100968547%22">BMC gastroenterology</searchLink> [BMC Gastroenterol] 2023 Mar 21; Vol. 23 (1), pp. 79. <i>Date of Electronic Publication: </i>2023 Mar 21.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22BioMed+Central%22">BioMed Central </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>100968547 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1471-230X (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%221471230X%22">1471230X </searchLink><i>NLM ISO Abbreviation: </i>BMC Gastroenterol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=36944922
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1186/s12876-023-02716-4
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 79
    Titles:
      – TitleFull: Glepaglutide, a novel glucagon-like peptide-2 agonist, has anti-inflammatory and mucosal regenerative effects in an experimental model of inflammatory bowel disease in rats.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Skarbaliene J
      – PersonEntity:
          Name:
            NameFull: Mathiesen JM
      – PersonEntity:
          Name:
            NameFull: Larsen BD
      – PersonEntity:
          Name:
            NameFull: Thorkildsen C
      – PersonEntity:
          Name:
            NameFull: Petersen YM
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 21
              M: 03
              Text: 2023 Mar 21
              Type: published
              Y: 2023
          Identifiers:
            – Type: issn-electronic
              Value: 1471-230X
          Numbering:
            – Type: volume
              Value: 23
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: BMC gastroenterology
              Type: main
ResultId 1